PARA vs RVPH · rev $5.0M vs $7.6M cap
PARA (PARA) versus Reviva Pharmaceuticals Holdings Inc. (RVPH) — a side-by-side from cached financials, not a winner call.
PARA (PARA) common stock.
Reviva Pharmaceuticals Holdings Inc. (RVPH) is a biotechnology company listed on NASDAQ.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
RVPH does not have a complete income-statement cache yet.
PARA currently screens at market cap $0. RVPH currently screens at market cap $7.6M.
Not investment advice. Open the PARA and RVPH stock pages for the full models.
Not investment advice.